Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors

A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations

(2018) David Tamborero et al.   CLINICAL CANCER RESEARCH

Clinicopathological correlation of PD-L1 expression in primary and metastatic breast Cancer and infiltrating immune cells

(2018) Ossama Tawfik et al.   HUMAN PATHOLOGY

Macrophages orchestrate breast cancer early dissemination and metastasis

(2018) Nina Linde et al.   Nature Communications

Immunological differences between primary and metastatic breast cancer

(2018) B Szekely et al.   ANNALS OF ONCOLOGY

Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer

(2018) Ahmed Basudan et al.   MOLECULAR CANCER RESEARCH

Clinical landscape of cancer metastases

(2018) Matias Riihimäki et al.   Cancer Medicine

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy

(2017) Teresa Davoli et al.   SCIENCE

Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer

(2017) Woosung Chung et al.   Nature Communications

The Cellular Origin and Evolution of Breast Cancer

(2017) Mei Zhang et al.   Cold Spring Harbor Perspectives in Medicine

Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases

(2017) Nolan Priedigkeit et al.   JAMA Oncology

Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer

(2016) Edith A. Perez et al.   JAMA Oncology

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

(2015) P. K. Brastianos et al.   Cancer Discovery

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

(2014) M. V. Dieci et al.   ANNALS OF ONCOLOGY

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

Metastatic triple-negative breast cancers at first relapse have fewer tumor-infiltrating lymphocytes than their matched primary breast tumors: a pilot study

(2013) Ashley Cimino-Mathews et al.   HUMAN PATHOLOGY

Inferring tumour purity and stromal and immune cell admixture from expression data

(2013) Kosuke Yoshihara et al.   Nature Communications

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

(2011) Bin-Zhi Qian et al.   NATURE